Clinical Development of Respiratory Syncytial Virus Antivirals-What We Can Learn From Oseltamivir

Clin Infect Dis. 2020 Dec 31;71(11):2796-2798. doi: 10.1093/cid/ciz1169.
No abstract available

Keywords: respiratory syncytial virus; antiviral; clinical trial; human-challenge study.

Publication types

  • Comment

MeSH terms

  • Antiviral Agents / therapeutic use
  • Double-Blind Method
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Oseltamivir / therapeutic use
  • Respiratory Syncytial Virus Infections* / drug therapy
  • Respiratory Syncytial Virus, Human*
  • Respiratory Tract Infections* / drug therapy
  • Transplant Recipients

Substances

  • Antiviral Agents
  • Oseltamivir